Wikipedia -WSS

Wikipedia

author：comprehensive 2025-10-03 01:04:49 - browse：69828

A sign of pharmaceutical company Bayer in front of a blossomed tree — coverage from STAT — INA FASSBENDER/AFP via Getty Images

More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two Phase 3 trials for its non-hormonal drug candidate, elinzanetant, meant to treat hot flashes. The results follow the recent market launch of Veozah, Astellas Pharma’s groundbreaking non-hormonal treatment for hot flashes, which was approved by the U.S. Food and Drug Administration last spring and received approval in the U.K., under the name Veozah, in December.

Elinzanetant is a neurokinin-1 and 3 receptor antagonist, and works by calming down the estrogen receptors in the brain that become hyperactive around menopause, causing hot flashes. The drug, a pill administered once a day, was shown to reduce both the frequency and intensity of hot flashes, and also met the secondary endpoints for improving sleep and quality of life, according to JoAnn Pinkerton, professor of obstetrics and gynecology and director of the Midlife Health at UVA Health, who is a clinical investigator for Bayer’s drug candidate.

Pinkerton said she was excited to see the broader quality of life improvements through elinzanetant: “Women have more than just hot flashes — it’s actually more about hot flushes, sweats, fatigue, lack of sleep and some of the mood changes that go on during [menopause].”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Weight loss drugs aren’t covered by Obamacare. That may change

WSS

New chart reveals military’s vast involvement in Operation Warp Speed

Opioid cravings were reduced by anti

Flagship Pioneering startup Sonata Therapeutics lays off 21

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

EMA weighs against approval for Mirati's lung cancer drug

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

explore

Wikipedia

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

Florida babysitter arrested over hot car death, authorities say

Guidelines to prevent youth baseball injuries need more muscle

A new drug could help frostbite victims avoid its ravages

How to save PrEP access — and even expand it

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Psychedelics group wrestles with new pharma identity

Why Marc Tessier

What does generative AI mean for health care? We asked experts

Surprise medical billing ban raises prices elsewhere

Wikipedia

Listen: BridgeBio's big week & Lilly's Alzheimer's data

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Obamacare plans could cover weight loss drugs

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

leisure time

hotspot

explore

explore